Valuation: DarioHealth Corp.

Market Cap 2.34Cr 2.1Cr 1.94Cr 1.76Cr 3.33Cr 219.59Cr 3.42Cr 23Cr 9.23Cr 117.65Cr 8.79Cr 8.6Cr 371.92Cr P/E 2026 *
-0.6x
P/E 2027 * -1.06x
Enterprise Value 3.48Cr 3.12Cr 2.87Cr 2.61Cr 4.94Cr 325.98Cr 5.08Cr 34Cr 14Cr 174.65Cr 13Cr 13Cr 552.11Cr EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.64x
Free-Float
78.35%
Yield 2026 *
-
Yield 2027 * -
1 day+16.02%
1 week-20.33%
Current month-20.33%
1 month-58.79%
3 months-68.80%
6 months-69.40%
Current year-79.00%
1 week 1.7
Extreme 1.6953
2.95
1 month 1.7
Extreme 1.6953
6.36
Current year 1.7
Extreme 1.6953
13.64
1 year 1.7
Extreme 1.6953
14.77
3 years 1.7
Extreme 1.6953
52
5 years 1.7
Extreme 1.6953
357.8
10 years 1.7
Extreme 1.6953
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 68 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap. Importance
24/09/26 Free

Chairman

54,000 0.5510%
24/09/26 Free

Director

61,000 0.6225%
24/09/26 Free

Director

28,000 0.2857%
Change 5-day change 1-year change 3-year change Capi.($)
+16.02%-20.33%-81.63%-88.83% 2.34Cr
-0.05%+0.97%-12.26%+17.55% 19TCr
-1.17%+2.74%+9.64%+43.73% 12TCr
-0.44%+4.42%-8.66%+18.52% 12TCr
-2.00%-2.72%-41.68%+4.07% 9.61TCr
+0.85%+2.41%-4.37%+76.50% 6.65TCr
-1.23%+7.29%+17.05%-9.39% 5.79TCr
-1.42%+3.66%-1.82%+62.49% 5.49TCr
+1.47%-2.27%-4.29%+54.83% 4.91TCr
-5.49%-7.87%-5.51%-11.16% 3.62TCr
Average +0.67%+0.12%-13.35%+16.83% 8TCr
Weighted average by Cap. -0.77%+2.37%-7.55%+27.17%

Financials

2026 *2027 *
Net sales 2.17Cr 1.95Cr 1.8Cr 1.63Cr 3.09Cr 203.9Cr 3.18Cr 22Cr 8.57Cr 109.24Cr 8.16Cr 7.99Cr 345.34Cr 2.95Cr 2.64Cr 2.44Cr 2.21Cr 4.19Cr 276.48Cr 4.31Cr 29Cr 12Cr 148.13Cr 11Cr 11Cr 468.27Cr
Net income -3.25Cr -2.91Cr -2.68Cr -2.44Cr -4.61Cr -304.56Cr -4.74Cr -32Cr -13Cr -163.18Cr -12Cr -12Cr -515.84Cr -2.21Cr -1.98Cr -1.83Cr -1.66Cr -3.14Cr -207.04Cr -3.22Cr -22Cr -8.71Cr -110.92Cr -8.29Cr -8.11Cr -350.66Cr
Net Debt 1.13Cr 1.02Cr 93.78L 85.17L 1.61Cr 106.39Cr 1.66Cr 11Cr 4.47Cr 57Cr 4.26Cr 4.17Cr 180.19Cr 2.51Cr 2.25Cr 2.07Cr 1.88Cr 3.56Cr 235.08Cr 3.66Cr 25Cr 9.89Cr 125.95Cr 9.41Cr 9.21Cr 398.16Cr
Projected Income Statement - Annual - DarioHealth Corp.
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
10/26/10 $2.390 +16.02% 59,351
09/26/09 $2.060 -13.26% 80,982
06/26/06 $2.375 -12.84% 14,896
05/26/05 $2.725 -8.25% 70,670
04/26/04 $2.970 -1.00% 58,715
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.390USD
Average target price
10.33USD
Spread / Average Target
+332.36%
  1. Stock Market
  2. Stocks
  3. DRIO Stock